Healthcare Trends 2018

Subscribe to industry newsletters

BHF supports low single exit price increase
BHF supports low single exit price increase

It is not sufficient for the pharmaceutical industry to say that the increase of 1,26% on single-exit price (SEP) is unfair and not related to market forces...

1 Feb 2018

Aspen seeks new formula
Aspen seeks new formula

Aspen Pharmacare is conducting a review of its global nutritionals business, with a view to entering into a strategic partnership or possibly a sale...

31 Jan 2018

Tony Wood, MD, MyDawa
E-health platform MyDawa disrupting Kenya's healthcare industry

The MyDawa solution is beneficial to consumers as they gain the advantage of having increased transparency, convenience and affordability. In addition, it ensures better pharmacovigilance as it tackles the issue of...

26 Jan 2018

Drug firm has a plan to bypass tap water
Drug firm has a plan to bypass tap water

Aspen Pharmacare's Cape Town-based subsidiary, Fine Chemicals Corporation, is so concerned about risks posed by the region's drought that it is investing in new infrastructure...

18 Jan 2018

Stephen Saad, CEO: Aspen. Photo: BusinessLIVE
Aspen claims manipulation

Aspen Pharmacare CEO Stephen Saad says he wants an inquiry into market manipulation after the company's shares slumped on rumours that Viceroy Research was preparing a report on the group...

12 Jan 2018

Australia takes GSK, Novartis to court over 'misleading' claims
Australia takes GSK, Novartis to court over 'misleading' claims

Drug giants GlaxoSmithKline and Novartis are being taken to court by Australia's consumer watchdog over "false or misleading" claims in the marketing of pain relief products...

7 Dec 2017

Competition Commission drops investigation into Aspen's alleged excessive pricing
Competition Commission drops investigation into Aspen's alleged excessive pricing

The Competition Commission has dropped its investigation into local company Aspen for allegedly charging excessive prices...

By Katharine Child 5 Oct 2017

Tina Eboka
Tina Eboka re-elected as HLG-MR vice-chair

Tina Eboka has been re-elected as vice chair of the OECD Nuclear Energy Agency High-Level Group on the Security of Supply of Medical Radioisotopes (HLG-MR)...

4 Aug 2017

Photo: Roche
Effects of dominance in price

There's been Increased focus on pharmaceutical pricing, both domestically and internationally...

By Nicci Botha 21 Jul 2017

Cipla collaborates with American Cancer Society to increase access to cancer treatment in Africa
Cipla collaborates with American Cancer Society to increase access to cancer treatment in Africa

Cipla has announced a groundbreaking market access agreement with the American Cancer Society, the Clinton Health Access Imitative and the pharmaceutical company, Pfizer...

Issued by Cipla 7 Jul 2017

Kalle Känd, CEO of Acino
Acino acquires South Africa's Litha Healthcare

Swiss pharmaceutical company, Acino, has bought Joburg-based Litha Healthcare, giving the former immediate access to the South African market...

4 Jul 2017

Photo: Roche
Trastuzumab and the high cost of cancer treatment

It seems cruel that drugs that can save the lives of thousands of cancer sufferers are so prohibitively expensive...

By Nicci Botha 21 Jun 2017

Bidvest and Adcock Ingram settle fine in merger case
Bidvest and Adcock Ingram settle fine in merger case

Bidvest's and Adcock Ingram's offer to pay a combined R2m fine without admitting guilt was accepted by the Competition Tribunal...

By Robert Laing 19 Jun 2017

Ascendis buys up more European pharma businesses
Ascendis buys up more European pharma businesses

Ascendis Health is on the acquisition trail once again with the purchase of Romanian pharma companies, Sunwave and NHP Natural Health Pharma...

5 Jun 2017

Recall issued for faulty EpiPen injector
Recall issued for faulty EpiPen injector

Mylan SA and Meridian Medical Technologies have issued an urgent recall of their EpiPen injector saying there was a defect with the device...

18 May 2017

Wavebreak Media Ltd ©
Hospital front shops help Clicks grow its footprint

Taking over the front shops in Netcare hospitals helped Clicks grow its flagship brand to 600 stores at the end of February, the retail group said in its interim results statement on Friday morning...

24 Apr 2017

Aspen's drug pricing faces EU, UK probes
Aspen's drug pricing faces EU, UK probes

Aspen Pharmaceuticals' failure to disclose its 2016 €5.2m Italian competition authorities fine for price gouging has backfired.

By Ann Crotty 19 Apr 2017

Cipla buys SA drug and devices maker
Cipla buys SA drug and devices maker

As third-biggest pharmaceutical company, Cipla Medpro SA, had acquired a 100% stake in local drug maker, Anmarat, for R26.3m...

12 Apr 2017

SafeCare standards re-accredited by ISQua
SafeCare standards re-accredited by ISQua

SafeCare provides healthcare clinics with the option to improve care for their patients with quality improvement standards they can comply with even under restricted conditions...

Issued by COHSASA 10 Mar 2017

Cipla to sell its 100% stake in SA agri and vet businesses
Cipla to sell its 100% stake in SA agri and vet businesses

Pharmaceutical company, Cipla, agreed to divest its 100% stake in Cipla Agrimed, South Africa and Cipla Vet, South Africa for a total consideration of R375m...

6 Mar 2017

Wanted: affordable medicines for all
Wanted: affordable medicines for all

Pneumonia, an acute infection of the lungs, is the biggest killer of children worldwide even though it is treatable and easily preventable with vaccines...

By Franck Kuwonu 13 Feb 2017

Roche under fire for cost of cancer meds
Roche under fire for cost of cancer meds

Breast cancer and HIV activists came out in their hundreds on Tuesday to demand that pharmaceutical giant Roche drop the price of its breast cancer drug...

By Neo Goba 10 Feb 2017

Photo credit: Roy Potterill
Patents and access to medicine

Rights activist group, Fix the patent laws, is taking a stand to get the South African law on medicine patents changed...

By Nicci Botha 2 Feb 2017

Johnson & Johnson plans to buy pharma group Actelion for $30bn
Johnson & Johnson plans to buy pharma group Actelion for $30bn

US pharmaceuticals giant Johnson & Johnson is buying Europe's biggest bio-pharmaceutical firm, Actelion, for $30bn in a deal that creates a new spin-off company...

27 Jan 2017

Aspen buys rights to market thrombolytic drugs in China
Aspen buys rights to market thrombolytic drugs in China

Aspen Pharmacare has added China to the countries where it owns the rights to two thrombolytic medications...

By Robert Laing 4 Jan 2017

Only a partnership-driven model can address the needs of patients in Africa
Only a partnership-driven model can address the needs of patients in Africa

I started my career as a doctor dealing with big healthcare firms and now I am the chief medical officer for GSK, so I have seen things from both sides.

By Murray Stewart 15 Nov 2016

Pyrotec PackMedia hosts Pharmaceutical Open Day
Pyrotec PackMedia hosts Pharmaceutical Open Day

During September, Pyrotec PackMedia held an Open Day for pharmaceutical customers to showcase the many benefits of the Fix-a-Form informational booklet label, among other brands in the company's stable...

Issued by Pyrotec 21 Oct 2016

Cipla and Teva extend supply and distribution chain in SA
Cipla and Teva extend supply and distribution chain in SA

The Competition Commission has approved an extension to the current supply and distribution agreement between Teva Pharmaceutical Industries and Cipla Medpro...

3 Oct 2016

US insurer ordered to defend prescription drug lawsuit
US insurer ordered to defend prescription drug lawsuit

Lawsuits by US states to hold pharmaceutical companies liable for their costs of dealing with prescription drug abuse is on the rise...

By Sharon Snell 26 Sep 2016

Show more